FOLFIRI-aflibercept
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFIRI-aflibercept, covering 2023-04-13 to 2023-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen [Phase 2]